Dexamethasone-Conjugated Low Molecular Weight Polyethylenimine as a Nucleus-Targeting Lipopolymer Gene Carrier
- 13 September 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 18 (6), 2029-2036
- https://doi.org/10.1021/bc070012a
Abstract
Dexamethasone, a glucocorticoid steroid, can dilate the nuclear pore complexes and translocate into the nucleus when it is bound to its glucocorticoid receptor, suggesting that the transport of DNA into the nucleus may be facilitated by the reagent. In this research, dexamethasone was conjugated to low molecular weight polyethylenimine (2kDa) for efficient translocation of the polymer/DNA complex into the nucleus. Polyethylenimine (PEI)–dexamethasone (PEI–Dexa) was synthesized by one-step reaction using the Traut’s reagent. In gel retardation assay, the PEI–Dexa/DNA complex was completely retarded at or above 0.3/1 weight ratio (polymer/DNA). The average size distributions and ζ-potential values of the complexes were measured at various weight ratios. In vitro transfection assay showed that the PEI–Dexa/DNA complex had higher gene delivery efficiency compared to PEI 2kDa/DNA complex. The localization of PEI–Dexa/plasmid DNA complexes in the nucleus was confirmed by using total internal reflection fluorescence and Nomarski differential interference contrast microscope as well as confocal microscope. Therefore, with efficient nuclear translocation and low cytotoxicity, PEI–Dexa may be useful for nonviral gene therapy.Keywords
This publication has 27 references indexed in Scilit:
- Nuclear envelope barrier leak induced by dexamethasoneJournal of Cellular Physiology, 2005
- Low molecular weight polyethylenimine for efficient transfection of human hematopoietic and umbilical cord blood-derived CD34+ cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2005
- Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginineJournal of Controlled Release, 2004
- Modular design of non-viral vectors with bioactive componentsTrends in Biotechnology, 2004
- Cationic corticosteroid for nonviral gene deliveryGene Therapy, 2004
- In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult ratsThe Journal of Gene Medicine, 2003
- Gene delivery by a steroid‐peptide nucleic acid conjugateThe FASEB Journal, 2002
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Selective enhancement of gene transfer by steroid-mediated gene deliveryNature Biotechnology, 2001
- Water-Soluble Lipopolymer for Gene DeliveryBioconjugate Chemistry, 2001